Guideline for the management of clinically localized prostate cancer: 2007 update. - Wikidata - awgldk - TriplyDB

Guideline for the management of clinically localized prostate cancer: 2007 update.

Guideline for the management of clinically localized prostate cancer: 2007 update.

http://www.wikidata.org/entity/Q34629234

about

Spatial Genome Organization and Its Emerging Role as a Potential Diagnosis Tool Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer Evidence-based recommendations on androgen deprivation therapy for localized and advanced prostate cancer Evolving Paradigm of Radiotherapy for High-Risk Prostate Cancer: Current Consensus and Continuing Controversies Extended lymph node dissection in robotic radical prostatectomy: Current status Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer Management of radiation-induced urethral strictures Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism Optimal management of prostate cancer with lethal biology--state-of-the-art local therapy High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer Inhibition of p21-activated kinase 6 (PAK6) increases radiosensitivity of prostate cancer cells Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease A novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapy Imaging on nodal staging of prostate cancer.Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.3D vs 2D laparoscopic radical prostatectomy in organ-confined prostate cancer: comparison of operative data and pentafecta rates: a single cohort study.Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease Non-invasive molecular imaging of prostate cancer lymph node metastasis.Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis.Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty Budget impact model: epigenetic assay can help avoid unnecessary repeated prostate biopsies and reduce healthcare spending.End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer Time trends and local variation in primary treatment of localized prostate cancer Establishment and genomic characterization of mouse xenografts of human primary prostate tumors.Does the time from biopsy to radical prostatectomy affect Gleason score upgrading in patients with clinical t1c prostate cancer?Reimbursement and use of intensity-modulated radiation therapy for prostate cancer.Multi-parametric magnetic resonance imaging as a management decision tool.What are the outcomes of radical prostatectomy for high-risk prostate cancer?Defining the level of evidence for technology adoption in the localized prostate cancer pathway Pre-treatment risk stratification of prostate cancer patients: A critical review.Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer - between options.Current status of radical prostatectomy for high-risk prostate cancer.Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer.Robotic prostatectomy: an update on functional and oncologic outcomes Functional and anatomical differences between continent and incontinent men post radical prostatectomy on urodynamics and 3T MRI: a pilot study.Patient perspective on watchful waiting/active surveillance for localized prostate cancer.Active surveillance in men with low-risk prostate cancer: current and future challenges.

P2860

Q26738275-E6A3B7DB-41A7-41D6-85F8-66424F6653DC Q26739708-8F7C1357-7603-415A-AF2F-E051161786EA Q26739738-FDC6C7C3-2D05-4F96-A09F-3DAB544D5424 Q26744606-A27549D3-01B1-4EFC-BBFB-BFEBCD2B1EAA Q26749073-B62B3753-E974-4406-ACFA-88ED98D0A12D Q26750620-9EA600E9-6C1E-4A2C-B5A6-75DE5542FE30 Q26773797-AB1F7BDE-0A98-466A-9555-443212A9DC9C Q26774456-BE594F0C-CDDB-47D4-841D-820FFE18E0FB Q26801188-79E01FCB-2860-48E7-9A40-F977505F32FC Q26996937-83CCD4FD-93AC-433A-B4E2-602BC5222350 Q28269570-999AE339-50D1-4D2D-BF13-61B4A5AA020B Q28534235-6702FFD5-7A24-4F0D-A93F-6FC50152F6C0 Q28543958-A98A582E-FAA2-4A41-AF87-412BE17D66C2 Q30244033-3661333B-2ED4-486F-A420-36F40E95F0E1 Q30393322-D88B4F72-77DD-4304-92CF-C4580A6D6D3D Q30936063-CDFF5ACF-F1FC-4647-8BDA-13A4FEC40695 Q33449075-74D4101A-3714-4F89-82E2-C942B502900C Q33557567-3706B9C1-1DD6-4DA1-A9DC-749E866AA6D7 Q33606053-97F549D1-9D03-4D0C-A12F-9424515FFA84 Q33607833-DCA17CEE-BD32-4E59-9264-6BF0F83A9FE3 Q33626084-23E94D43-4F83-4784-8CAD-5018186C3D3D Q33651148-961E27A7-ACC6-4CB7-AEFC-F0F133A3AC5D Q33652793-099D06EB-7C52-409E-B871-D194BB72DC07 Q33676155-42FD3B06-A75A-461C-AA0F-AC7766F56D81 Q33710948-BDA13037-1556-419A-AC62-F6753412B063 Q33745240-84F30011-2005-4212-AB3F-D4AA9276400F Q33780058-B2B2ED56-EBC5-464B-BB58-8E093D9CC58F Q33833551-46AAAF94-67A5-4988-827A-E5032778FEA6 Q33890160-D9E2C2F7-6C98-4018-A252-0B8CC666AAB9 Q33927594-F33B8C47-899F-4E56-BFEC-6474AF4C9721 Q34061419-AC743CF4-83AD-4F60-8576-29501E2321E9 Q34268868-999344A4-0F54-4B51-B2D9-816D597CFD1B Q34288796-0357E177-B1C7-4DF9-AE88-70728A6C402F Q34342191-102F5205-60AE-4248-A9A7-8E2C55295AE7 Q34346841-548C8676-6D7A-4D6F-918C-A86F0605C8A5 Q34366865-0D367E46-4C49-417E-8C4E-1F23121C2C07 Q34375988-3EF576DE-69B2-4BE4-8797-F5CECFFD9ECB Q34381531-CFE5705A-20A2-40B9-859F-BC530A6F7EC9 Q34419421-348267F4-1DC0-4D36-B461-315C3FDC0414 Q34448113-824F48E8-42D4-4F73-9DCC-BC20DECA503E

P2860

Guideline for the management of clinically localized prostate cancer: 2007 update.

http://www.wikidata.org/entity/Q34629234

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Guideline for the management of clinically localized prostate cancer: 2007 update.

@ast

Guideline for the management of clinically localized prostate cancer: 2007 update.

@en

Guideline for the management of clinically localized prostate cancer: 2007 update.

@nl

type

label

Guideline for the management of clinically localized prostate cancer: 2007 update.

@ast

Guideline for the management of clinically localized prostate cancer: 2007 update.

@en

Guideline for the management of clinically localized prostate cancer: 2007 update.

@nl

prefLabel

Guideline for the management of clinically localized prostate cancer: 2007 update.

@ast

Guideline for the management of clinically localized prostate cancer: 2007 update.

@en

Guideline for the management of clinically localized prostate cancer: 2007 update.

@nl

P1433

Q34629234-DAA43A4F-B6FE-481D-A765-1CB00DFFE195

P1476

Q34629234-6692E2D8-D5A3-42DF-81E9-23DEF1032C81

P2093

Q34629234-08A48364-0F6C-490A-B39B-49E6817B7AF1

Q34629234-107EC536-6389-4141-A1AB-345911535EA7

Q34629234-25681E6B-85FB-47B2-BECC-73FB8543D74C

Q34629234-2AE91853-57F8-41EC-96C3-310A35D83D2B

Q34629234-2FE5543C-A6DF-4194-9F13-C6018EF2E6C5

Q34629234-4A9B182F-3DBE-4540-9A01-DAC6333284F6

Q34629234-4BF9F56E-7C89-422C-93F6-28FD26A76FC4

Q34629234-6233EFCD-1094-415E-8A4A-F17F37151512

Q34629234-719CD6A3-07B8-411E-B940-80D6B78DE078

Q34629234-8411069D-EBCB-41F3-87DF-6BAFB90E42B8

P304

Q34629234-BCD86C64-F0D2-4190-ACE7-66063C09DFDE

P31

Q34629234-92EB8157-EA07-41EC-97E4-7C8D0AFCB477

P356

Q34629234-C2C3AC65-0455-4282-9BAA-F3E4737F7D63

P407

Q34629234-006BA14B-532B-4C6D-8F5B-101638300AB6

P433

Q34629234-FF7CFDA6-DCEE-44B5-9632-55E334CF8359

P478

Q34629234-9B8C6F8D-FE31-4D0D-AF8B-0591B6CDD401

P50

Q34629234-23C66112-74B9-441A-B296-4EF0E385BC3F

P577

Q34629234-9A1E6910-9B9E-4289-89FD-C4FC6E465799

P5875

Q34629234-DB521773-0A62-41EC-9AD7-4BDE810DB277

P698

Q34629234-0070D7DC-126A-45DD-943C-0EDB06DCAF87

P356

J.JURO.2007.03.003

P1433

The Journal of Urology

P1476

Guideline for the management of clinically localized prostate cancer: 2007 update

@en

P2093

AUA Prostate Cancer Clinical Guideline Update Panel

http://www.w3.org/2001/XMLSchema#string

Anthony V D'Amico

http://www.w3.org/2001/XMLSchema#string

Arthur L Burnett

http://www.w3.org/2001/XMLSchema#string

Catherine M Tangen

http://www.w3.org/2001/XMLSchema#string

Celestia S Higano

http://www.w3.org/2001/XMLSchema#string

Edith D Canby-Hagino

http://www.w3.org/2001/XMLSchema#string

Gunnar Aus

http://www.w3.org/2001/XMLSchema#string

Ian Thompson

http://www.w3.org/2001/XMLSchema#string

James Brantley Thrasher

http://www.w3.org/2001/XMLSchema#string

Javier Hernandez

http://www.w3.org/2001/XMLSchema#string

P304

2106-2131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2007.03.003

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6323783

http://www.w3.org/2001/XMLSchema#string

P698

17509297

http://www.w3.org/2001/XMLSchema#string